JPRN-UMIN000003397已完成未知
Feasibility study of Docetaxel plus Bevacizumab in selected patient with previously treated advanced NSCLS(non-squamous). - Feasibility study of Docetaxel plus Bevacizumab in selected patient with previously treated advanced NSCLS(non-squamous).
Cancer Institute Hospital Japanese Foundation for Cancer Research0 个研究点目标入组 15 人开始时间: 2010年3月29日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 15
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients with Brain metastasis. Patinets with symptomatic congestive heart failure,unstable angina pectoris,cardiac arrhythmias,thorombotic events,a history of gross hemoptysis.
研究者
相似试验
已完成
1 期
Phase I/II study of Docetaxel with Bevacizumab for refractory and geriatric non-squamous non-small cell lung canceron-Squamous Non-Small Cell Lung CancerJPRN-UMIN000006152Chiba Tokushukai Hospital20
已完成
2 期
Phase II Study of Docetaxel+Bevacizumab with non-squamous non-small cell lung cancer for patients pretreated with chemotherapyon-small-cell lung cancerJPRN-UMIN000005077Tochigi Cancer Center22
已完成
不适用
A feasibility study of Docetaxel/Bevacizumab in elderly patients with advanced non-small cell lung cancer (TORG1014)on-small cell lung cancerJPRN-UMIN000004240Thoracic Oncology Research Group(TORG)12
已完成
2 期
A phase II study of Docetaxel with Bevacizumab for EGFR mutation negative previously treated non-squamous non-small cell lung canceron-Squamous Non-Small Cell Lung CancerJPRN-UMIN000006532ihon University School of Medicine30
已完成
不适用
A phase II study of Docetaxel with Bevacizumab for previously treated non-squamous non-small cell lung cancer.non-squamous non-small cell lung cancer.JPRN-UMIN000008687First Department of Internal Medicine,25